Stocks and Investing Stocks and Investing
Wed, January 4, 2023
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (TS) at Buy with Increased Target to $42 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Toni Kaplan Upgraded (TRU) to Buy and Decreased Target to $78 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Dan Salmon Initiated (TTD) at Hold and Held Target at $43 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Chris Snyder Upgraded (TT) to Strong Buy and Increased Target to $200 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Allison Poliniak Cusic Maintained (UPS) at Buy with Decreased Target to $195 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Allison Poliniak Cusic Maintained (UNP) at Hold with Decreased Target to $200 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
James Monigan Maintained (TFII) at Buy with Increased Target to $115 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Edward Kelly Downgraded (TGT) to Hold and Decreased Target to $142 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (ALL) at Buy with Increased Target to $157 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
James Ricchiuti Upgraded (SSYS) to Strong Buy and Held Target at $15 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Tim Lugo Initiated (SPRY) at Buy on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Edward Kelly Maintained (SYY) at Buy with Decreased Target to $87 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Blostein Initiated (STT) at Hold on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Zach Parham Downgraded (SM) to Hold and Decreased Target to $46 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Dan Salmon Initiated (SNAP) at Strong Buy and Held Target at $12 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (SPGI) at Buy with Decreased Target to $388 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Derek Johnston Downgraded (BXP) to Hold and Decreased Target to $74 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Vikram Malhotra Maintained (BXP) at Strong Buy with Decreased Target to $85 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BX) at Strong Buy with Decreased Target to $86 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Laura Champine Upgraded (BURL) to Hold and Increased Target to $200 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Allison Poliniak Cusic Maintained (CSX) at Hold with Increased Target to $32 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Upgraded (CE) to Buy and Increased Target to $125 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Ghansham Panjabi Downgraded (CCK) to Hold and Held Target at $80 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Darren Aftahi Upgraded (ARBK) to Hold and Increased Target to $1 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (ARMK) at Hold with Increased Target to $44 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Derek Johnston Downgraded (AVB) to Hold and Decreased Target to $179 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (AUPH) at Buy with Increased Target to $11 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ZYME) at Hold with Decreased Target to $8 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Koji Ikeda Downgraded (ZI) to Hold and Decreased Target to $34 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $20 on, Jan 4th, 2023

Robert Burns Maintained (ADCT) at Strong Buy with Decreased Target to $20 on, Jan 4th, 2023


Published on 2024-10-28 00:44:10 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Maintained "ADC Therapeutics SA" (ADCT) at Strong Buy with Decreased Target from $21 to $20 on, Jan 4th, 2023.

Robert has made no other calls on ADCT in the last 4 months.



There are 4 other peers that have a rating on ADCT. Out of the 4 peers that are also analyzing ADCT, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $7 on, Monday, November 14th, 2022
  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $7 on, Wednesday, November 9th, 2022


These are the ratings of the 2 analyists that currently disagree with Robert

  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $20 on, Wednesday, November 9th, 2022
  • Brian Cheng of "JP Morgan" Initiated at Buy and Held Target at $5 on, Wednesday, September 21st, 2022
Contributing Sources